125163-15-7 Usage
Structure
A derivative of aniline with a fluorine substitution at the 4 position and a methoxy group at the 5 position.
Applications
a. Synthesis of pharmaceuticals
b. Synthesis of agrochemicals
c. Building block in organic chemistry
Toxicity
Can be toxic if ingested or absorbed through the skin.
Irritation
Can cause irritation to the skin, eyes, and respiratory system.
Mutagenic and carcinogenic potential
Suspected mutagen and carcinogen, so proper handling and precautions are necessary.
Flammable
May be flammable or reactive with other chemicals.
Corrosive
Can cause chemical burns or damage to materials it comes into contact with.
Storage
Should be stored in a cool, dry, and well-ventilated area, away from incompatible substances and sources of ignition.
Disposal
Dispose of according to local, national, and international regulations for hazardous materials.
Gloves
Chemical-resistant gloves to prevent skin contact.
Eye protection
Goggles or face shield to protect eyes from contact or splashes.
Respiratory protection
Use a NIOSH-approved respirator if ventilation is inadequate or if exposure levels are unknown.
Protective clothing
Lab coats, aprons, or other protective clothing to prevent skin contact.
Check Digit Verification of cas no
The CAS Registry Mumber 125163-15-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,1,6 and 3 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 125163-15:
(8*1)+(7*2)+(6*5)+(5*1)+(4*6)+(3*3)+(2*1)+(1*5)=97
97 % 10 = 7
So 125163-15-7 is a valid CAS Registry Number.
125163-15-7Relevant articles and documents
HEPATITIS C VIRUS INHIBITORS
-
, (2016/01/21)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa
Reck, Folkert,Ehmann, David E.,Dougherty, Thomas J.,Newman, Joseph V.,Hopkins, Sussie,Stone, Gregory,Agrawal, Nikunj,Ciaccio, Paul,McNulty, John,Barthlow, Herbert,O'Donnell, Jennifer,Goteti, Kosalaram,Breen, John,Comita-Prevoir, Janelle,Cornebise, Mark,Cronin, Mark,Eyermann, Charles J.,Geng, Bolin,Carr, Greg R.,Pandarinathan, Lakshmipathi,Tang, Xuejun,Cottone, Andrew,Zhao, Liang,Bezdenejnih-Snyder, Natascha
, p. 5392 - 5409 (2014/12/10)
Type II bacterial topoisomerases are well validated targets for antimicrobial chemotherapy. Novel bacterial type II topoisomerase inhibitors (NBTIs) of these targets are of interest for the development of new antibacterial agents that are not impacted by
Studies on proton pump inhibitors. I. Synthesis of 8-[(2-benzimidazol)sulfinyl]-5,6,7,8-tetrahydroquinolines and related compounds
Uchida,Morita,Chihiro,Kanbe,Yamasaki,Yabuuchi,Nakagawa
, p. 1517 - 1523 (2007/10/02)
-
